Bridging the gap with evidence-based medicine.
  REPORTS MEETINGS RECENT  PUBLICATIONS USEFUL  LINKS CONTACT  
 
57th Annual Meeting of the American Academy of Dermatology
New Orleans, Louisiana / March 19-24, 1999

Effective Emollient Use in Atopic Dermatitis: A Promising Adjunct to Traditional Treatment
New Orleans - The prevalence of atopic dermatitis is on the increase and is estimated to affect up to 12% of the populations of northern countries, such as Canada, the United Kingdom, Finland and Sweden. Treatment remains challenging. While topical corticosteroids remain the preferred treatment of atopic dermatitis, particularly during acute episodes, researchers have shown that drug-free emollients can favourably influence the course of the disease. An emollient added to steroids can restore the skin’s moisture which is important for patient comfort and may actually facilitate resolution. In addition, steroid penetration of the skin can be enhanced. Some researchers have shown that emollients can be substituted in part for corticosteroids in cases of mild to moderate dermatitis, thus avoiding the adverse local and systemic effects that can potentially arise with frequent steroid use. The drug-free emollient, Vernix, is increasingly recommended as a useful adjunct to traditional treatment, particularly because it replicates the naturally occurring components of vernix caseosa–the protective covering of the skin of the fetus and newborn—restoring normal physiologic protection to the skin. In some cases, patients using Vernix have been able to stop corticosteroid treatment completely.
Reducing Steroid Drug Use

Effective treatment of atopic dermatitis includes consistent usage of an emollient for the dry skin component, with periodic use of a topical steroid agent for the inflammatory component, based on the severity of the disease and response to treatment, reported Dr. James Q. Del Rosso, Clinical Assistant Professor in the Department of Dermatology at the University of Nevada School of Medicine, Las Vegas.
  Speaking about new treatment findings for common dermatologic conditions, Dr. Del Rosso referred to a study published last November in the British Journal of Dermatology finding that once-daily application of topical corticosteroids is as effective as more frequent applications based on several studies of common dermatoses, including eczema and psoriasis. “The important point is that you can reduce the frequency of application, reduce the amount of drug applied, reduce the risk of local side effects and maintain efficacy at a lower cost,” Dr. Del Rosso said.
  The findings also imply, he added, that an effective treatment strategy might utilize a low-potency agent in an emollient lotion during the day, while a higher potency agent in an ointment base could be used at night during periods of exacerbation.
  Over-the-counter emollients can be chosen based on patient preference and lack of irritation. “In general, skin
cleansers and emollient lotions devoid of fragrances are preferred because, as every dermatologist knows, patients with atopic dermatitis are more sensitive to a variety of contactants in the environment,” Dr. Del Rosso said.
Vernix may be the emollient that comes closest to what is appropriate for human skin, commented Dr. Guy Sylvestre, a Montreal dermatologist. “In the pharmacy, there is a 30-foot-long shelfful of different formulations, oils, occlusives and other products and strategies,” he noted. According to Dr. Sylvestre, “this one is the simplest and most efficient yet.”
Vernix emulates the vernix caseosa which covers and protects the neonate during the first few weeks of life. Its main ingredients are squalene and squalane, cholesterol, tryglycerides and monoester waxes, all of which are found on human skin to varying degrees. The balance of ingredients, however, closely match the balance found on the skin of neonates.

Replicating Nature

“The formula is simple—Vernix reconstitutes the natural protective nature of the skin,” Dr. Sylvestre said. “It imitates nature.” In addition, Vernix is odourless, colourless, hypoallergenic, non-comedogenic and cosmetically acceptable to apply and wear daily, according to dermatologists.
 
Emollient use can be critical to the comfort of atopic dermatitis patients, noted Dr. Stephen P. Stone, Associate Professor of Dermatology at the Southern Illinois School of Medicine. While it is well accepted that patients will do better with limited bathing and application of a greasy substance such as petroleum jelly, the practice is not without drawbacks, Dr. Stone reported here. According to Dr. Stone, petroleum jelly is not particularly effective if it is applied to skin that is already dry. He added, “basically, you are sealing out the moisture rather than sealing it in.”
By comparison, Vernix is composed of natural ingredients that appear to recreate the natural physiology of skin protection found in the newborn period.
“In my 22 years of practice in dermatology, this is my favourite formula to moisturize and rebuild the natural protective barrier of the skin,” Dr. Sylvestre remarked.

Integrating Emollients

Emollients can be an integral part of a well-rounded management program for atopic dermatitis, said Dr. Richard G. Fried, Adjunct Professor of Dermatology at Thomas Jefferson University, Philadelphia, Pennsylvania, who spoke on non-pharmacologic treatment of psychocutaneous problems. “It’s a pretty wide spectrum according to the patient and the clinical setting,” he reported. “It takes a very low level (of support) in terms of offering some hope for the patients and some good education so they will comply with everything from emollients to corticosteroids.”
However, corticosteroids are known to produce a wide range of side effects locally over the long term, including thinning of the skin, striae, persistent erythema, atrophy and telangiectasias. It is known that a host of other complications can occur, including growth inhibition in children, if steroids become systemically available via percutaneous absorption.
Dermatologists familiar with Vernix said that in clinic, the cream has helped patients reduce their dependence on corticosteroids or eliminate their use entirely. Dr. Charles Lynde, Assistant Professor of Dermatology at the University of Toronto, Ontario, said he has used Vernix to treat approximately 100 patients with atopic dermatitis—in particular, hand dermatitis. In one case, the hand dermatitis of a hairdresser in her early 20s was resolved in four weeks using Vernix. She discontinued steroids completely, having previously been recalcitrant to 15 or more steroid preparations. “The patients were quite surprised,” Dr. Lynde commented,
and added, “These were people who had been using steroids for a long time.”
In other cases, patients with mild atopic dermatitis were asked to apply a topical steroid to one lesion and apply Vernix to a lesion on the opposite side of the body. In general, the lesions treated with Vernix improved to a greater degree than those treated with steroids. A similar protocol has been described in the literature by researchers at the Department of Child Health in Manchester, U.K., who concluded that differing topical treatments compared simultaneously on opposite sides of the body can help discern optimal therapy options for patients with atopic dermatitis.
  “Obviously, this was not a double-blind, prospective trial, but many of these patients have already tried a lot of other products and have not had benefit,” Dr. Lynde said.
According to Dr. Sylvestre, many eczema patients have been able to use less topical steroid since starting with Vernix. In addition, while Vernix will not eliminate inflammation like corticosteroids do, regular usage has resulted in fewer lesions, more comfort and less itching and inflammation as it eliminates the dryness component of the disease.
  “The results are remarkable,” Dr. Sylvestre said. “Some people completely stop using topical steroids when before they were addicted.”

Benefits Elucidated

The use of Vernix is not limited to atopics. Dermatologists report successfully using the emollient to treat nipples chapped from breast feeding, dry skin eczema, and skin dried out from skiing and other outdoor winter activities. The cream has proven helpful for preserving and protecting elderly skin, preventing diaper rash, and softening the skin of the abdomen, hips and breasts of pregnant women, possibly reducing the risk of associated stretch marks. At the University of Cincinnati, Dr. Steven Hoath, Pediatrics Professor and Director of The Skin Sciences Institute is using Vernix to treat pediatric patients with severe burns and plans to determine whether the product is useful for treating wound infections.
  Other uses aside, Vernix has clearly found a place in the armamentarium of some Canadian dermatologists who are helping their patients manage atopic dermatitis. “If you find something that can keep things under control, can be used as an adjunct and can even be used as a steroid sparer, that’s a great thing to have,” Dr. Lynde said.
  More studies involving Vernix are planned or underway, including one examining its mechanism of action.
© 1999 Health Odyssey International Inc. All rights reserved. Integrative Medicine Report® is an independent medical news reporting service providing educational updates reflecting peer opinion from scientific and clinical meetings worldwide. Views expressed are those of the participants and do not necessarily reflect those of the publisher. Any therapies mentioned in this report should be used in accordance with the recognized prescribing information in Canada. No claims or endorsements are made for any products, uses or doses presently under investigation. No part of this newsletter may be reproduced in any form or distributed without written consent of the publisher. Information provided herein is not intended to serve as the sole basis for individual care. Our objective is to facilitate health care professionals’ understanding of current trends in medicine. Your comments are encouraged.
 
Copyright Health Odyssey © 2006. Integrative Medicine ® is a Registered Trade Mark.